Clinical Trials Browser

INDUSTRY × Sarcoma × exatecan × Clear all

NCT00055939 2012-05-16

Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

Phase 2 Completed

Sarcoma

NCT00055952 2012-05-16

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Phase 2 Completed

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor